News and Press Releases
Chorioamnionitis
-
Tucson startup looks to human trials for drug to treat lung inflammation
Jan 2022
-
Aqualung Therapeutics Corp., Closes a $2.5M Convertible Note Raise With a Committed Series A Lead Investor
January 2022
-
CEO & Founder of Aqualung Therapeutics Corp., Joe G.N. Garcia MD to Present Corporate Update at the Annual Biotech Showcase
Dec 2021
-
Aqualung Therapeutics Selected to Present at the Phoenix 2021 Venture Madness Competition
August 2021
-
Aqualung Therapeutics Corp. Awarded $300 Thousand From National Institute of Health (NIH) to Develop a Novel Therapeutic for Pregnant Women at Risk for Preterm Births
Sept 2020
-
Healing lungs, improving data, oncology research and more
June 2020